COMMUNIQUÉS West-GlobeNewswire

CellAegis Announces Completion of Patient Enrollment in First North American Study for Innovative Heart Attack Therapy Using autoRIC®
11/09/2018
TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for [...]
Advanced Proteome Therapeutics Provides Overview of Current Activities and Strategic Objectives
11/09/2018
VANCOUVER, British Columbia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to provide an overview of current projects prior to [...]
Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence
11/09/2018
ENGLEWOOD, Colo., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced submission of an Investigational Device [...]
Vectura Group plc: Interim Results
11/09/2018
This contains inside information Vectura Group plc Vectura regaining momentum with continued inhaled revenue and adjusted EBITDA growth Chippenham, UK - 11 September 2018 : Vectura Group plc (LSE: VEC) ("Vectura" or " [...]
ORYZON receives approval to start ALICE: a Phase IIa clinical trial in AML with Iadademstat (ORY-1001)
11/09/2018
The study will be done in elderly Acute Myeloid Leukemia (AML) patients not eligible for intensive chemotherapy It is the first Phase II study of Iadademstat (ORY-1001) in combination therapy MADRID, Spain and CAMBRIDGE [...]
Tetra Bio-Pharma Accelerates its European Drug Registration Activities
11/09/2018
PPP001 and PPP005 Eligible for Marketing Approval ORLEANS, Ontario, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in [...]
Atara Biotherapeutics Appoints Cancer Research and Clinical Development Veteran, Roy Baynes, to its Board of Directors
11/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
BioSig Technologies Issues Shareholder Letter
11/09/2018
Highlights include FDA 510(k) clearance and Nasdaq uplisting Santa Monica, CA, Sept. 11, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD) a medical device company developing a proprietary [...]
Professor Cosman Redefines Robotic Surgery in Australia
11/09/2018
BRIGHTON, Mich., Sept. 11, 2018 (GLOBE NEWSWIRE) -- FlexDex Inc. is pleased to announce the first surgical procedure performed utilizing the FlexDex ® Needle Driver took place on July 31, 2018 in Australia. Prof. Peter [...]
Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash
11/09/2018
SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered [...]
KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
11/09/2018
Highlights of KP415.A01 Oral HAP Trial Results: Mean Drug Liking (E max ) of KP415 Prodrug (serdexmethylphenidate) at both 120 mg and 240 mg doses were statistically significantly lower than Focalin ® XR at 80 mg Mean [...]
IMV Inc. Announces Phase 2 Basket Trial in Collaboration with Merck to Evaluate DPX-Survivac in Combination with KEYTRUDA® Across Five Solid Tumor Indications
11/09/2018
Clinical Expansion Marks Third Phase 2 Clinical Trial Combining IMV’s Lead Immunotherapy Candidate with Merck’s Marketed Checkpoint Inhibitor HALIFAX, Nova Scotia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: [...]
Sennheiser Communications evolves in new set-ups
11/09/2018
Investor news 11 September 2018 Sennheiser Communications evolves in new set-ups Copenhagen/September 11, 2018 – William Demant Holding A/S (William Demant) and Sennheiser electronic GmbH & Co. KG (Sennheiser) see [...]
Transactions in relation to share buyback program
11/09/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Amedisys Wins 15 Aster Awards for Home Health and Hospice Marketing
11/09/2018
Most of Any Healthcare Organization in 2018 BATON ROUGE, La., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, recently [...]
Idera Pharmaceuticals Announces Corporate Organizational Changes
11/09/2018
- Bryant D. Lim appointed as General Counsel and Secretary of the Board of Directors - - Chief Financial Officer Louis J. Arcudi III departing the company related to company consolidation to Pennsylvania - EXTON, Pa., [...]
Revive Therapeutics Introduces RELICANN™ a New Brand for Hemp-based CBD Wellness and Medical Cannabis Market
11/09/2018
TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”) , a specialty cannabis company focused on the research, development and [...]
IRADIMED CORPORATION Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan
11/09/2018
WINTER SPRINGS, Fla., Sept. 11, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced receipt of [...]
Amicus Therapeutics Announces Board Appointments
11/09/2018
Lynn D. Bleil Appointed to Board of Directors Michael G. Raab Named Lead Independent Director CRANBURY, N.J., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused [...]

Pages